checkAd
    Revvity Inc Anleihe 3,30 % bis 15.09.2029 Anleihe
    90,30
     
    %
    -0,22 %
    Letzter Kurs 09:26:39 Düsseldorf
    90,36
     
    %
    50.000 STK
    Geldkurs 12:06:26
    91,01
     
    %
    50.000 STK
    Briefkurs 12:06:26
    ISIN: US714046AG46 · WKN: A2R7WK

    Neueste Nachrichten

    Revvity to Present at Goldman Sachs Global Healthcare Conference
    28.05.24 · Business Wire (engl.) · PerkinElmer
    Revvity Announces Financial Results for the First Quarter of 2024
    29.04.24 · Business Wire (engl.) · PerkinElmer
    Revvity Board Declares Quarterly Dividend
    25.04.24 · Business Wire (engl.) · PerkinElmer
    Revvity to Present at BofA Securities 2024 Health Care Conference
    25.04.24 · Business Wire (engl.) · PerkinElmer
    Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners
    15.04.24 · Business Wire (engl.) · PerkinElmer
    Revvity To Hold Earnings Call on Monday, April 29, 2024
    04.04.24 · Business Wire (engl.) · PerkinElmer
    Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software
    02.04.24 · Business Wire (engl.) · PerkinElmer
    Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group
    20.03.24 · Business Wire (engl.) · PerkinElmer
    Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication
    18.03.24 · Business Wire (engl.) · PerkinElmer
    Revvity to Present at Upcoming Investor Conferences
    21.02.24 · Business Wire (engl.) · PerkinElmer
    Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023
    01.02.24 · Business Wire (engl.) · PerkinElmer
    Revvity Board Declares Quarterly Dividend
    25.01.24 · Business Wire (engl.) · PerkinElmer